Involvement of Sphingosine 1-phosphate (SIP)/S1P3 Signaling in Cholestasis-induced Liver Fibrosis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2009 Sep 5

PMID 19729475

Citations 49

Authors

Changyong Li

Xiangming Jiang

Lin Yang

Xihong Liu

Shi Yue

Liying Li

Affiliations

Soon will be listed here.

Abstract

Bioactive sphingosine 1-phosphate (S1P) and S1P receptors (S1PRs) have been implicated in many critical cellular events, including inflammation, cancer, and angiogenesis. However, the role of S1P/S1PR signaling in the pathogenesis of liver fibrosis has not been well documented. In this study, we found that S1P levels and S1P(3) receptor expression in liver tissue were markedly up-regulated in a mouse model of cholestasis-induced liver fibrosis. In addition, the S1P(3) receptor was also expressed in green fluorescent protein transgenic bone marrow (BM)-derived cells found in the damaged liver of transplanted chimeric mice that underwent bile duct ligation. Silencing of S1P(3) expression significantly inhibited S1P-induced BM cell migration in vitro. Furthermore, a selective S1P(3) receptor antagonist, suramin, markedly reduced the number of BM-derived cells during cholestasis. Interestingly, suramin administration clearly ameliorated bile duct ligation-induced hepatic fibrosis, as demonstrated by attenuated deposition of collagen type I and III, reduced smooth muscle alpha-actin expression, and decreased total hydroxyproline content. In conclusion, our data suggest that S1P/S1P(3) signaling plays an important role in cholestasis-induced liver fibrosis through mediating the homing of BM cells. Modulation of S1PR activity may therefore represent a new antifibrotic strategy.

Citing Articles

Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms.

Markovic D, Maslovaric I, Kovacic M, Vignjevic Petrinovic S, Ilic V Int J Mol Sci. 2023; 24(5).

PMID: 36901933 PMC: 10003516. DOI: 10.3390/ijms24054497.

Neuron-Glial Antigen 2 Participates in Liver Fibrosis via Regulating the Differentiation of Bone Marrow Mesenchymal Stem Cell to Myofibroblast.

Yang L, Zhang H, Dong C, Yue W, Xue R, Liu F Int J Mol Sci. 2023; 24(2).

PMID: 36674693 PMC: 9864665. DOI: 10.3390/ijms24021177.

Role of sphingosine kinase and sphingosine-1-phosphate receptor in the liver pathology of mice infected with Plasmodium berghei ANKA.

Techarang T, Jariyapong P, Punsawad C PLoS One. 2022; 17(3):e0266055.

PMID: 35333897 PMC: 8956183. DOI: 10.1371/journal.pone.0266055.

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy.

Gupta P, Taiyab A, Hussain A, Alajmi M, Islam A, Hassan M Cancers (Basel). 2021; 13(8).

PMID: 33920887 PMC: 8071327. DOI: 10.3390/cancers13081898.

Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling.

Zhao X, Yang L, Chang N, Hou L, Zhou X, Yang L Cell Death Dis. 2020; 11(5):379.

PMID: 32424179 PMC: 7235026. DOI: 10.1038/s41419-020-2582-1.

References

Nodai A, Machida T, Izumi S, Hamaya Y, Kohno T, Igarashi Y . Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci. 2007; 80(19):1768-76. DOI: 10.1016/j.lfs.2007.02.008. View

Xia J, Dai C, Michalopoulos G, Liu Y . Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006; 168(5):1500-12. PMC: 1606599. DOI: 10.2353/ajpath.2006.050747. View

Salomone S, Yoshimura S, Reuter U, Foley M, Thomas S, Moskowitz M . S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol. 2003; 469(1-3):125-34. DOI: 10.1016/s0014-2999(03)01731-x. View

Schwab S, Pereira J, Matloubian M, Xu Y, Huang Y, Cyster J . Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 2005; 309(5741):1735-9. DOI: 10.1126/science.1113640. View

Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S . Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol. 2007; 37(4):395-404. DOI: 10.1165/rcmb.2007-0065OC. View

Ezure T, Sakamoto T, Tsuji H, Lunz 3rd J, Murase N, Fung J . The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000; 156(5):1627-39. PMC: 1876916. DOI: 10.1016/S0002-9440(10)65034-1. View

Bataller R, Brenner D . Liver fibrosis. J Clin Invest. 2005; 115(2):209-18. PMC: 546435. DOI: 10.1172/JCI24282. View

Jun D, Lee J, Choi B, Koh T, Ha D, Jeong M . Sphingosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes. Endocrinology. 2006; 147(12):5835-44. DOI: 10.1210/en.2006-0579. View

Spiegel S, English D, Milstien S . Sphingosine 1-phosphate signaling: providing cells with a sense of direction. Trends Cell Biol. 2002; 12(5):236-42. DOI: 10.1016/s0962-8924(02)02277-8. View

10.

Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia J, Schwabe R . Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol. 2006; 45(3):429-38. DOI: 10.1016/j.jhep.2006.04.014. View

11.

Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C . Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol. 2005; 38(2):135-51. DOI: 10.1016/j.biocel.2005.08.021. View

12.

Lebman D, Spiegel S . Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J Lipid Res. 2008; 49(7):1388-94. PMC: 2431110. DOI: 10.1194/jlr.R800008-JLR200. View

13.

Forbes S, Russo F, Rey V, Burra P, Rugge M, Wright N . A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology. 2004; 126(4):955-63. DOI: 10.1053/j.gastro.2004.02.025. View

14.

Son B, Marquez-Curtis L, Kucia M, Wysoczynski M, Turner A, Ratajczak J . Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006; 24(5):1254-64. DOI: 10.1634/stemcells.2005-0271. View

15.

Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H . Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol. 2000; 20(24):9247-61. PMC: 102182. DOI: 10.1128/MCB.20.24.9247-9261.2000. View

16.

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

17.

Kallis Y, Alison M, Forbes S . Bone marrow stem cells and liver disease. Gut. 2006; 56(5):716-24. PMC: 1942133. DOI: 10.1136/gut.2006.098442. View

18.

Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H . Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004; 40(6):1304-11. DOI: 10.1002/hep.20452. View

19.

Alvarez S, Milstien S, Spiegel S . Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab. 2007; 18(8):300-7. DOI: 10.1016/j.tem.2007.07.005. View

20.

Hla T . Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol. 2004; 15(5):513-20. DOI: 10.1016/j.semcdb.2004.05.002. View